Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2013 Q2- Text added to 2013 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
ACE, addiction, addressing, administer, aging, aid, aimed, alternative, analyzed, analyzing, annum, applied, apply, assist, beta, BRAF, Caliper, CardioPredict, category, cf, cfDNA, channel, chronic, commonly, companion, concordance, copy, covenant, decide, delivery, DGX, dosing, Earlier, EGFR, employee, exhausted, explore, factor, fixed, foregoing, hand, highlight, identification, imminent, implicated, influence, inhibitor, introduced, LabChip, mediate, melanoma, metabolism, methadone, moderate, Nasdaq, NYSE, October, opioid, optimize, overdose, oxycodone, pain, PDI, PDII, PerkinElmer, PKI, plasma, platelet, portfolio, predict, pressure, primary, promotion, prospect, prospectively, public, purport, Quest, rare, relevance, relevant, represented, reserve, retrospectively, safety, scope, solution, strength, Subtopic, suffer, terminating, text, thinner, tool, toxicity, ultrasensitive, unequalled, warfarin
Valuein 2013 Q2 filing- Value in 2013 Q3 filing
Original filings
Filing view